Overview

The GMO Alternative Allocation Fund aims to generate positive total return while enhancing portfolio diversification through low correlation to traditional risk assets. The Fund offers broad exposure across multiple asset classes liquid alternative categories, including merger arbitrage/event-driven, equity market neutral, global macro, relative value quality, and volatility. We believe the Fund’s success is driven by the following key features: 

Dynamic Allocation on Two Levels

  • Top-down. The GMO Asset Allocation team allocates capital based on risk and opportunity at the portfolio level. This is especially true at valuation extremes, when investors need risk management the most.
  • Bottom-up. The underlying investment strategies dynamically alter exposures and risk levels in an alpha-proportional manner.

Diversity of Risk and Return

  • The Fund accesses a broad set of risk factors including carry, momentum, quality, value, and volatility.
  • The team combines skill-based alpha strategies with those designed to capture alternative risk premia.

Efficient use of Capital - The team employs overlays that enable exposures greater than 100%, enabling a concentration of alpha not possible in a traditional fund-of-fund model.

Transparency and Liquidity - The portfolio management team has complete transparency, not just of positions but of the rationale and conviction levels of the underlying teams. Investors benefit from daily liquidity.

Experience - GMO has over 25 years of experience in both managing individual alternative strategies and integrating them into multi-strategy solutions.

Facts

Doc Table
Fund Inception Date May 1, 2019
CUSIP 362014466
Fund Total Assets as of 28/02/2026 $813mm USD

Share Class R6

Ticker Symbol GAAKX
CUSIP 36256V601
Net Expense Ratio 1 2.16%
Gross Expense Ratio 2 2.45%
Adjusted Expense Ratio 3 1.00%

1 Net Expense Ratio reflects the reduction of expenses from fee reimbursements. The fee reimbursements will continue until at least June 30, 2026. Elimination of this reimbursement will result in higher fees and lower performance.

2 Gross Expense Ratio is equal to the Funds Total Annual Operating Expenses set forth in the Funds most recent prospectus dated June 30, 2025.

3 Adjusted expense ratio excludes certain investment-related costs, such as dividend and interest expense on short sales and interest expense incurred through entering into reverse repurchase agreements. The total of these costs, where applicable, can be found in the most recent prospectus.

Performance

Documents

Literature

Fact Sheet Download
Prospectus Download
Summary Prospectus Download
Statement of Additional Information Download
Download All Download

Downloads

Performance Download
Portfolio Composition Download
Holdings Download
Download All Download

Commentary & Attribution

Investor Information

Annual Financial Statements and Other Information Download
Annual Report Download
Semi-Annual Financial Statements and Other Information Download
Semi-Annual Report Download
NAVs and Distributions Download
Distribution Dates Download
Tax-Related Distribution Information Download
Download All Download

Risks

Risks associated with investing in the Fund may include: (1) Management and Operational Risk: the risk that GMO's investment techniques will fail to produce desired results, including annualized returns and annualized volatility; (2) Derivatives and Short Sales Risk: the use of derivatives involves the risk that their value may not change as expected relative to changes in the value of the underlying assets, pools of assets, rates, currencies or indices. Derivatives also present other risks, including market risk, illiquidity risk, currency risk, credit risk, and counterparty risk; and (3) Leveraging Risk: the use derivatives and securities lending creates leverage. Leverage increases the Funds losses when the value of its investments (including derivatives) declines. For a more complete discussion of these and other risks, please consult the Fund's Prospectus.

Disclosures

An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. Read the prospectus carefully before investing. Please see prospectus above.

The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated.